10. ovarian cancer
screenings: CA-125 test
In 2018, only 3.6% of cancers diagnosed were ovaries, but it is still essential to detect this disease at an early stage. In addition to routine pelvic exams, a CA-125 blood test is used to measure a protein, CA-125. A high rate may indicate ovarian cancer. However, endometriosis and pelvic inflammatory diseases also increase CA-125 levels, so this screening is unreliable. ACS explains that the next step could be a transvaginal ultrasound.
Following: The most common cancer among women in the world